Loading candles…
Fabtech Technologies Ltd, incorporated in 2018, is a biopharma engineering company that provides turnkey design, engineering, and manufacturing solutions for cleanrooms, sterile processing, and containment. Its services include design, engineering, and manufacturing tailored for critical environments. The company primarily serves the pharmaceutical, biotech, and healthcare industries across more than 60 countries worldwide. Fabtech Technologies supports global pharmaceutical companies in establishing and scaling manufacturing facilities. It operates globally but does not have any publicly listed shares or known subsidiaries.
| Type | Details | Date |
|---|---|---|
| Dividend | To consider dividend for the Financial Year ended March 31, 2026. | 27 Apr 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 | 27 Apr 2026 |
| Results - Q3-FY25 | To consider and approve the financial results for the Quarter ended December 31, 2025 | 2 Feb 2026 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.